Summit Global Investments’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Sell
11,797
-11,829
-50% -$271K 0.01% 476
2026
Q1
$550K Buy
+23,626
New +$509K 0.03% 313
2025
Q4
Sell
-11,509
Closed -$210K 511
2025
Q3
$210K Buy
+11,509
New +$224K 0.01% 449
2023
Q1
Sell
-138,188
Closed -$1.83M 540
2022
Q4
$1.83M Sell
138,188
-1,941
-1% -$25.5K 0.15% 148
2022
Q3
$1.63M Sell
140,129
-17,509
-11% -$240K 0.15% 147
2022
Q2
$2.33M Buy
157,638
+24,106
+18% +$395K 0.21% 116
2022
Q1
$2.58M Sell
133,532
-22,668
-15% -$405K 0.19% 120
2021
Q4
$2.69M Buy
156,200
+99,200
+174% +$1.69M 0.17% 114
2021
Q3
$952K Buy
+57,000
New +$853K 0.07% 215

Other funds holding INVA

Summit Global Investments's INVA Position: Q2 2026 in Review

Summit Global Investments reduced its Innoviva (INVA) stake by 50% in Q2 2026, selling an estimated $271K and leaving 11,797 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #476.

Summit Global Investments first reported a position in INVA in Q3 2021 and has held it in 9 quarters since. The position peaked at $2.69M in Q4 2021. 82 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Summit Global Investments held 11,797 shares of Innoviva worth $268K as of Q2 2026.
  • Summit Global Investments sold 11,829 Innoviva shares in Q2 2026, an estimated $271K.
  • Innoviva made up 0.01% of Summit Global Investments's portfolio in Q2 2026, its #476 holding.
  • Summit Global Investments first reported a position in Innoviva in Q3 2021 and has held it in 9 quarters since.
  • Summit Global Investments's Innoviva position peaked at $2.69M in Q4 2021.
  • 82 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.